Deletions in MAP3K7 have recently been associated with early PSA recurrence, and in tumours that do not contain the TMPRSS2-ERG gene fusion, a tumour-suppressor role for MAP3K7 has been proposed (Kluth et al., 2013). The gene discussed is MAP3K7; the disease is neoplasm.